Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06458569

NK-ORB Expression of Mu Receptor on Lymphocytes in Rehabilitation

Sponsor: IRCCS San Raffaele Roma

View on ClinicalTrials.gov

Summary

Chronic pain is a serious disorder that causes physical suffering and emotional distress. NK cells are cytotoxic granular cells playing a crucial role in innate immunity. Recent studies described modulation of the percentage of B lymphocytes and NK cells expressing the μ opioid receptor as a potential marker for measuring pain. Neuropathic pain sufferers have decreased NK cell function, highlighting the need of further investigating the effect of opioid receptor expression on lympoid cells defining their potential relevance as a pain monitor marker. Opioid receptors expressed on NK, B and T cells are a possible candidate for objective monitoring of pain in patients.

Official title: Employment of Natural Killer Opioid Receptor as a Biomarker to Ameliorate the Efficacy of the Rehabilitation Program in a Patient-oriented Strategy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2023-10-03

Completion Date

2026-04-29

Last Updated

2024-06-13

Healthy Volunteers

Not specified

Conditions

Interventions

OTHER

Rehabilitation

3-weeks rehabilitation in hospital

Locations (1)

IRCCS San Raffaele

Roma, Italy